Driver Incapacity

Exploring neurological pathways, in the blink of an eye

Driver Incapacity

Moving beyond drowsiness measurement, we are unlocking the ability to detect driver incapacity including that caused by medical conditions.

Optalert’s scientists and researchers are now using our infrared reflectance blepharometry and patented algorithms to identify biomarkers for monitoring neurological disorders, such as: 

  • Epilepsy
  • Alzheimer’s
  • Parkinson’s
  • Depression
  • Traumatic brain injury (TBI)
  • Other neurological disorders

This is the next threshold for automotive OEMs and Advanced Driver Assistance Systems. If you would like to know more,contact our team: 

Blepharometry is Optalert’s unique form of objective eyelid measurement. This innovative technology gives researchers the power to identify, track and ultimately enable clinicians to: 

  • Find neurological biomarkers 
  • Screen patients to allow for early intervention
  • Identify stages of disease progression 
  • Monitor response to treatment 
  • Improve the accuracy and efficiency of clinical trials 
  • Monitor and measure drowsiness or alertness effects of medication 
  • Provide simultaneous computerised reaction testing and Infrared reflectance recording capabilities 

If you are working in a neurological or other research field and would like to know how Optalert could assist with your research, don’t hesitate to contact us today at